认知正常的墨西哥裔美国人主观认知能力下降的α-2巨球蛋白水平:一项HABLE研究。

Current neurobiology Pub Date : 2019-04-01
James R Hall, April R Wiechmann, Leigh A Johnson, Melissa L Edwards, Sid E O'Bryant
{"title":"认知正常的墨西哥裔美国人主观认知能力下降的α-2巨球蛋白水平:一项HABLE研究。","authors":"James R Hall,&nbsp;April R Wiechmann,&nbsp;Leigh A Johnson,&nbsp;Melissa L Edwards,&nbsp;Sid E O'Bryant","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The presence of Subjective Cognitive Decline (SCD) in the absence of objective change and the inflammatory biomarker Alpha 2 Macroglobulin (A2M) have both been implicated in preclinical Alzheimer's disease. Mexican Americans are population with high rates of cardiovascular and inflammatory disorders.</p><p><strong>Objectives: </strong>The current study investigated the levels of A2M in cognitively normal Mexican Americans with and without complaints of cognitive decline.</p><p><strong>Method: </strong>293 (243 females, 50 males) community-based cognitively normal older Mexican Americans from the ongoing Health and Aging Brain among Latino Elders (HABLE) study were grouped based on subjective cognitive decline and blood samples were assayed by electrochemiluminescence to determine levels of A2M.</p><p><strong>Results: </strong>Participants with SCD had significantly higher levels of A2M than those without SCD. Females with SCD had a significantly higher level of A2M.</p><p><strong>Conclusions: </strong>Results suggest that higher levels of A2M, a marker of neuronal injury, may be involved in subtle changes in cognitive functioning recognizable to persons reporting SCD but too subtle to be objectively measured. Longitudinal research is needed to assess the impact of SDC and A2M in progression to MCI and dementia in Mexican Americans.</p>","PeriodicalId":89670,"journal":{"name":"Current neurobiology","volume":"10 1","pages":"22-25"},"PeriodicalIF":0.0000,"publicationDate":"2019-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6499402/pdf/nihms-1014310.pdf","citationCount":"0","resultStr":"{\"title\":\"Levels of α-2 Macroglobulin in cognitively normal Mexican- Americans with Subjective Cognitive Decline: A HABLE Study.\",\"authors\":\"James R Hall,&nbsp;April R Wiechmann,&nbsp;Leigh A Johnson,&nbsp;Melissa L Edwards,&nbsp;Sid E O'Bryant\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The presence of Subjective Cognitive Decline (SCD) in the absence of objective change and the inflammatory biomarker Alpha 2 Macroglobulin (A2M) have both been implicated in preclinical Alzheimer's disease. Mexican Americans are population with high rates of cardiovascular and inflammatory disorders.</p><p><strong>Objectives: </strong>The current study investigated the levels of A2M in cognitively normal Mexican Americans with and without complaints of cognitive decline.</p><p><strong>Method: </strong>293 (243 females, 50 males) community-based cognitively normal older Mexican Americans from the ongoing Health and Aging Brain among Latino Elders (HABLE) study were grouped based on subjective cognitive decline and blood samples were assayed by electrochemiluminescence to determine levels of A2M.</p><p><strong>Results: </strong>Participants with SCD had significantly higher levels of A2M than those without SCD. Females with SCD had a significantly higher level of A2M.</p><p><strong>Conclusions: </strong>Results suggest that higher levels of A2M, a marker of neuronal injury, may be involved in subtle changes in cognitive functioning recognizable to persons reporting SCD but too subtle to be objectively measured. Longitudinal research is needed to assess the impact of SDC and A2M in progression to MCI and dementia in Mexican Americans.</p>\",\"PeriodicalId\":89670,\"journal\":{\"name\":\"Current neurobiology\",\"volume\":\"10 1\",\"pages\":\"22-25\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6499402/pdf/nihms-1014310.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current neurobiology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current neurobiology","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景:在没有客观变化的情况下,主观认知能力下降(SCD)和炎症生物标志物α 2巨球蛋白(A2M)的存在都与临床前阿尔茨海默病有关。墨西哥裔美国人是心血管疾病和炎症性疾病高发人群。目的:目前的研究调查了认知正常的墨西哥裔美国人的A2M水平,有和没有认知能力下降的抱怨。方法:将293名(243名女性,50名男性)来自正在进行的拉丁美洲老年人大脑健康和老化(HABLE)研究的社区认知正常的墨西哥裔美国老年人根据主观认知能力下降进行分组,并采用电化学发光法检测血液样本的A2M水平。结果:SCD患者的A2M水平明显高于非SCD患者。SCD女性患者A2M水平显著增高。结论:结果表明,较高水平的A2M(神经元损伤的标志)可能与SCD患者认知功能的细微变化有关,这些变化可被识别,但由于太微妙而无法客观测量。需要进行纵向研究来评估SDC和A2M对墨西哥裔美国人MCI和痴呆进展的影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Levels of α-2 Macroglobulin in cognitively normal Mexican- Americans with Subjective Cognitive Decline: A HABLE Study.

Background: The presence of Subjective Cognitive Decline (SCD) in the absence of objective change and the inflammatory biomarker Alpha 2 Macroglobulin (A2M) have both been implicated in preclinical Alzheimer's disease. Mexican Americans are population with high rates of cardiovascular and inflammatory disorders.

Objectives: The current study investigated the levels of A2M in cognitively normal Mexican Americans with and without complaints of cognitive decline.

Method: 293 (243 females, 50 males) community-based cognitively normal older Mexican Americans from the ongoing Health and Aging Brain among Latino Elders (HABLE) study were grouped based on subjective cognitive decline and blood samples were assayed by electrochemiluminescence to determine levels of A2M.

Results: Participants with SCD had significantly higher levels of A2M than those without SCD. Females with SCD had a significantly higher level of A2M.

Conclusions: Results suggest that higher levels of A2M, a marker of neuronal injury, may be involved in subtle changes in cognitive functioning recognizable to persons reporting SCD but too subtle to be objectively measured. Longitudinal research is needed to assess the impact of SDC and A2M in progression to MCI and dementia in Mexican Americans.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信